Annual Meeting 2015: Design and results of the PERSIST-1 trial of pacritinib in myelofibrosis - 101793

Spotlight
Video

Annual Meeting 2015: Design and results of the PERSIST-1 trial of pacritinib in myelofibrosis

VJHemOnc has 1607 videos Subscribe Here

Loading........
Description: At ASCO 2015, Dr Jean-Jacques Kiladjian explains the design and recent results of the phase 3 PERSIST-1 trial of pacritinib compared with best available therapy for patients with myelofibrosis, with specific focus on the impact on thrombocytopenia, low-platelet count, and transfusion independence.

—————

The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Website: http://www.vjhemonc.com/...
Twitter: https://twitter.com/VJHemOn...
Facebook: https://www.facebook.com/vj...
LinkedIn: https://www.linkedin.com/co...
Shared By : VJHemOnc
Posted on : 07/10/15
Added : 3 years ago